DECOY20

· Indaptus Therapeutics, Inc

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for DECOY20, covering 2026-01-13 to 2026-01-13. Get the full timeline:

Most recent: Clinical Trial Update: Study of DECOY20 With or Without Tislelizumab in Patients With Advanced Solid Tumors [Phase 1, Phase 2]